Next Proteins has US and international patents for a wide range of protein containing beverage uses. The company’s work has resulted in a worldwide patent portfolio consisting of six patents granted in the US and patents issued across 33 additional countries including China, Japan, Russia and throughout Europe.
For more than nine years, Next Proteins has singularly researched, funded and developed its carbonated protein technology, which is embodied in the world’s first carbonated high protein fitness drink, XAPP.
Each can of XAPP contains electrolytes and 25g of whey protein isolate which makes it the perfect beverage for before and after workouts, the company claims.
David Jenkins, founder and CEO of Next Proteins, said: “Our innovative Intellectual Property Umbrella allows us to produce carbonated protein drinks in nearly every soft drink plant around the world.
“Next Proteins’ patent portfolio provides an unimpeded path to leadership in the explosive growth category of RTD protein and enhanced functional beverages. This patented technology redefines the market by providing significant flexibility and cost reductions for all protein drink manufacturers, whether carbonated or still, in the US or abroad.”
Next Proteins’ patent portfolio covers every major existing and emerging carbonated soft drink market in the world.
Source: Next Proteins
© FoodBev Media Ltd 2024